Iuliu Hatieganu University Of Medicine And Pharmacy
Clinical trials sponsored by Iuliu Hatieganu University Of Medicine And Pharmacy, explained in plain language.
-
Could a common anesthetic help prevent liver cancer from coming back?
Disease control Recruiting nowThis study looks at whether adding lidocaine to standard sedation during radiofrequency ablation for liver cancer can reduce inflammation and lower the chance of the cancer returning. The researchers focus on a process called NETosis, which is linked to tumor growth and spread. O…
Phase: NA • Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New pain drug could cut opioid use after pancreatic surgery
Symptom relief Recruiting nowThis study tests whether a continuous infusion of nefopam, a non-opioid painkiller, can reduce opioid use and pain after pancreatoduodenectomy (a major pancreatic surgery). About 93 adults will be randomly assigned to receive nefopam, lidocaine, or standard epidural pain relief. …
Phase: PHASE4 • Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Cancer patients asked: which pills can you ditch?
Knowledge-focused Recruiting nowThis study looks at how cancer patients in palliative care feel about stopping medications that are not for their cancer. About 120 participants will fill out questionnaires, watch an educational video, and receive a brochure. Researchers want to see if this information changes t…
Phase: NA • Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC